Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

By afschroeder • November 23, 2025

Bolla E, Semb AG, Petri M, Sfikakis PP, Artim-Esen B, Hernandez-Molina G, Hachulla E, Direskeneli H, Karpouzas GA, Zucchi D, Goyal M, Costedoat-Chalumeau N, Tincani A, Yazici A, Lerang K, Troldborg A, Ajeganova S, Popkova TV, Svenungsson E, Pantazis N, Tektonidou MG; SURF-SLE and APS collaborators. Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries. Lancet Rheumatol. 2025 Nov 19:S2665-9913(25)00257-7. doi: 10.1016/S2665-9913(25)00257-7. Epub ahead of print. PMID: 41274305.

Tags: Harbor UCLA, Publications, Rheumatology

Validation of the Standardized Outcomes in Nephrology – Life Participation (SONG-LP) Instrument in People Receiving Dialysis

Burnett CT, Hughes A, Jaure A, Ju A, Guha C, Howell M, Manera K, Cheetham M, Wilkie M, Loud F, Figueiredo A, Cheung C, Schwartz[...]

Impact on daptomycin resistance using combination of daptomycin plus ceftaroline in daptomycin-susceptible and -resistant Staphylococcus aureus

Mishra NN, Black CA, Abdelhady W, Farah S, Rodas NA, Brizuela J, Lopez CB, Artaza JN, Sakoulas G, Rose WE. Impact on daptomycin resistance using[...]

The Invisible Patient: Coronary Artery Calcium Screening and the Evidence Gap in Rural Women of Color

Ansari S, Budoff MJ. The Invisible Patient: Coronary Artery Calcium Screening and the Evidence Gap in Rural Women of Color. JACC Adv. 2026 Jun 3:102853.[...]